Home » Topics » Medical technology

Medical technology
RSS

Other Financings Of Public Biotechnology Companies: August 2007

Sep. 10, 2007

Pozen, AstraZeneca Starting Phase III Program In Arthritis

Sep. 10, 2007

Revenge of the Entrepreneurs: See It Now At TheFunded.com

Sep. 10, 2007

By Cynthia Robbins-Roth

Alnylam And Isis Launch JV To Focus On MicroRNA

Sep. 10, 2007

By Trista Morrison

BioWorld Stock Report For Public Biotechnology Companies

Sep. 10, 2007

Stock Winners and Losers For The Week

Sep. 10, 2007

Other News To Note

Sep. 10, 2007

Stock Indexes

Sep. 10, 2007

Money Raised Year To Date

Sep. 10, 2007

Money Raised By Month

Sep. 10, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...